全文获取类型
收费全文 | 2460040篇 |
免费 | 182910篇 |
国内免费 | 11174篇 |
专业分类
耳鼻咽喉 | 32724篇 |
儿科学 | 74929篇 |
妇产科学 | 65556篇 |
基础医学 | 345494篇 |
口腔科学 | 72349篇 |
临床医学 | 224890篇 |
内科学 | 474085篇 |
皮肤病学 | 53515篇 |
神经病学 | 188027篇 |
特种医学 | 92961篇 |
外国民族医学 | 359篇 |
外科学 | 372933篇 |
综合类 | 71423篇 |
现状与发展 | 24篇 |
一般理论 | 751篇 |
预防医学 | 179218篇 |
眼科学 | 59207篇 |
药学 | 187325篇 |
124篇 | |
中国医学 | 12294篇 |
肿瘤学 | 145936篇 |
出版年
2021年 | 21967篇 |
2019年 | 21133篇 |
2018年 | 29566篇 |
2017年 | 23324篇 |
2016年 | 24995篇 |
2015年 | 29947篇 |
2014年 | 40710篇 |
2013年 | 56731篇 |
2012年 | 78861篇 |
2011年 | 83244篇 |
2010年 | 50441篇 |
2009年 | 46561篇 |
2008年 | 76079篇 |
2007年 | 80093篇 |
2006年 | 80638篇 |
2005年 | 76732篇 |
2004年 | 72613篇 |
2003年 | 68959篇 |
2002年 | 66141篇 |
2001年 | 127432篇 |
2000年 | 130371篇 |
1999年 | 108357篇 |
1998年 | 28407篇 |
1997年 | 24922篇 |
1996年 | 24810篇 |
1995年 | 23721篇 |
1994年 | 21768篇 |
1993年 | 19852篇 |
1992年 | 81343篇 |
1991年 | 78283篇 |
1990年 | 75391篇 |
1989年 | 72722篇 |
1988年 | 66183篇 |
1987年 | 64507篇 |
1986年 | 60702篇 |
1985年 | 57669篇 |
1984年 | 42059篇 |
1983年 | 35824篇 |
1982年 | 19726篇 |
1979年 | 37322篇 |
1978年 | 25618篇 |
1977年 | 21818篇 |
1976年 | 19976篇 |
1975年 | 21307篇 |
1974年 | 25851篇 |
1973年 | 24754篇 |
1972年 | 23135篇 |
1971年 | 21566篇 |
1970年 | 20240篇 |
1969年 | 18929篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
13.
Depeng Meng Yichen Meng Bingyang Li Guigang Zeng Bin Zhang Chunlin Hou Haodong Lin Yueping Ouyang 《Journal of orthopaedic science》2021,26(3):409-414
BackgroundComminuted patellar fractures are not rare, and the ideal treatment method remains controversial. The present study was conducted to evaluate effects and compare complications of two different methods used to treat comminuted patellar fractures.MethodsFrom March 2010 to August 2016, 102 cases of 34-C2 or 34-C3 comminuted patellar fractures were treated at our hospital, wherein patients received two different treatments: titanium cable tension band with cerclage method (group A) and intrafragmentary screws with X-shaped plating technique (group B). At follow-ups, articular step-off, range of motion (ROM), Lysholm scores, time of union, and complications were recorded and analyzed. Radiographic and clinical data as well as rate of complications were statistically analyzed.ResultsIn total, 87 patients were included in the final analysis (n = 47 in group A and n = 40 in group B). No significant differences were noted in terms of cost of implant, age, gender, rate of 34-C3 fractures, rate of layered inferior pole fractures, postoperative articular step-off and union time. At 2-year follow-up, average Lysholm scores, ROM and rate of complications were (89.0 ± 4.5), (122°±12°) and (27.7%) in group A and (90.2 ± 3.9), (124°±11°) and (17.5%) in group B, respectively, with no significant differences (p > 0.05). The mean time of surgery in group B was shorter than that in group A with significant difference (p < 0.05).ConclusionsTreatment using the intrafragmentary screws and plate method for amenable comminuted patellar fractures achieved similar complication rate and favorable functional outcomes at the 2-year follow-up, which was comparable to the titanium cable tension band with cerclage method. Thus, the intrafragmentary screws and plate method is effective, safe and convenient for 34-C2/C3 comminuted patellar fractures, especially appropriate for patients with layered fragments. 相似文献
14.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
15.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
16.
17.
Clinical & Experimental Metastasis - 相似文献
18.
19.
20.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献